Applied Genetics Inc. has developed a new method for increasing DNA repair in skin by topical delivery of DNA repair enzymes.
The specific aim of the Phase I research is to measure the extent and fidelity of the enhanced DNA repair before proceeding to photocarcinogenesis experiments in animals in Phase II. The UV-DNA specific endonuclease V from bacteriophage T4 was introduced into UV-irradiated cells by treatment with endonuclease encapsulated in liposomes and also by gene transfection, resulting in increased DNA repair. Phase I will determine if the enhanced repair is safe and effective in preventing UV mutagenesis. The spontaneous and UV- induced mutation frequency in liposome treated and transfected human cells will be measured. In addition the removal of both pyrimidine and 6-4 photoproducts and the resulting repair patch size will be measured in these cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA052401-02
Application #
3506811
Study Section
Special Emphasis Panel (SSS (B3))
Project Start
1990-04-01
Project End
1993-08-31
Budget Start
1991-09-13
Budget End
1992-08-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Agi Dermatics
Department
Type
DUNS #
City
Freeport
State
NY
Country
United States
Zip Code
11520
Yarosh, D; Alas, L G; Yee, V et al. (1992) Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Res 52:4227-31
Kripke, M L; Cox, P A; Alas, L G et al. (1992) Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci U S A 89:7516-20